Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 12/20 | 0.55 |
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | F11 | P03951 | 2/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12524043 | 0.94 | LIPG (0.65) | LPLLIPGHIF1ACA1CA2 | |
| SCHEMBL19213278 | 0.89 | P4HB (0.50) | LPLLIPGHIF1ACA1CA2 | |
| SCHEMBL15583748 | 0.89 | LPL (0.47) | LPLLIPGHIF1ACA1CA2 | |
| SCHEMBL14934699 | 0.89 | LPL (0.47) | LPLLIPGHIF1ACA1CA2 | |
| SCHEMBL19834910 | 0.89 | LPL (0.57) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL15165484 | 0.88 | LPL (0.55) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL12938319 | 0.87 | LPL (0.51) | LPLLIPGHIF1ACA1CA2 | |
| SCHEMBL12984850 | 0.85 | LIPG (0.54) | LPLLIPGHIF1ACA1CA2 | |
| SCHEMBL22770715 | 0.85 | LIPG (0.54) | LPLLIPGHIF1ACA1CA2 | |
| SCHEMBL22269908 | 0.85 | LIPG (0.54) | LPLLIPGHIF1ACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6559310-B2 | Reacting a halogen aromatic derivative at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a suitable base for covalently coupling organic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-05-06 | — | — | US | claimed |
| US-20020193604-A1 | Aryl borates | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-12-19 | — | — | US | claimed |
| US-20020032339-A1 | ARYL BORATES | BORON MOLECULAR LIMITED (AU) | 2002-03-14 | — | — | US | claimed |
| US-20250340563-A1 | FUSED PYRIDAZINE DERIVATIVES AS NLRP3 INHIBITORS | TAKEDA DEVELOPMENT CENTER AMERICAS, INC. | 2025-11-06 | — | — | US | disclosed |
| US-20250154107-A1 | 3,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof | BEIGENE SWITZERLAND GMBH (CH) | 2025-05-15 | — | — | US | disclosed |
| EP-4504733-A1 | FUSED PYRIDAZINE DERIVATIVES AS NLRP3 INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2025-02-12 | — | — | EP | disclosed |
| EP-4448513-A1 | 3, 4-DIHYDROISOQUINOLIN-1 (2H) -ONES DERIVATIVES AS STING ANTAGONISTS AND THE USE THEREOF | BeiGene Switzerland GmbH (CH) | 2024-10-23 | — | — | EP | disclosed |
| CN-118440514-A | Benzodithiadiazole organic dye, preparation method and application thereof, and electrowetting display ink | 光显科技(广东)有限公司 | 2024-08-06 | — | — | CN | disclosed |
| EP-3680947-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2024-05-29 | — | — | EP | disclosed |
| CN-115925751-B | Organic metal iridium complex, preparation method and application thereof in organic electroluminescent device | 吉林奥来德光电材料股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
| WO-2023194964-A1 | FUSED PYRIDAZINE DERIVATIVES AS NLRP3 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-12 | — | — | WO | disclosed |
| WO-2010093425-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | SEPRACOR INC. (US) | 2010-08-19 | — | — | WO | disclosed |
| US-20100204214-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. | 2010-08-12 | — | — | US | disclosed |
| US-20100144999-A1 | METHOD FOR PRODUCING AROMATIC POLYMER | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-20100144999-A1 | METHOD FOR PRODUCING AROMATIC POLYMER | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-20100109517-A1 | PYRENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2147944-A1 | PYRENE POLYMER AND LUMINESCENT ELEMENT MADE WITH THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-01-27 | — | — | EP | disclosed |
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | US | disclosed |
| WO-2008140133-A1 | BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LEF1, CYP1B1, ESR1 | LPL 1927/4885LIPG 3067/4885HIF1A 2858/4885 |
| US-20020193604-A1 | Aryl borates | BRD4, ABL1, BRD3 | LPL 4181/4885LIPG 4621/4885HIF1A 4507/4885 |
| US-20100109517-A1 | PYRENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | TERB1, AHR, CYP1A1 | LPL 3983/4885LIPG 4317/4885HIF1A 1799/4885 |
| US-20020032339-A1 | ARYL BORATES | TBCB, HAT1, UBE2B | LPL 4584/4885LIPG 4847/4885HIF1A 3796/4885 |
| US-20250340563-A1 | FUSED PYRIDAZINE DERIVATIVES AS NLRP3 INHIBITORS | NLRP3, NLRP1, NOD1 | LPL 3144/4885LIPG 4256/4885HIF1A 2638/4885 |
| US-20100204214-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | HRH3, HRH4, HRH2 | LPL 3488/4885LIPG 3575/4885HIF1A 3217/4885 |
| US-20250154107-A1 | 3,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof | STING1, IRF3, MAVS | LPL 2932/4885LIPG 449/4885HIF1A 2379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.